Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: fluconazole / dilantin / penicillins / ertapenem attending: chief complaint: rash, facial swelling major surgical or invasive procedure: lip biopsy history of present illness: 50 y/o female with a h/o pituitary miroadenoma s/p resection, htn, and panhypopituitarism who presented to the ed with oral pain and rash. the rash start 2 days ago. she does not note oral pain. she does feel that the rash is painful on the back and the dorsal hands. she denies pain of the genitals. she and her daughters state that she has not taken any herbals or any other oral medications other than what she is precribed. ed course: vitals on presentation: t 99.5 hr 117 bp 130/69 rr 22 100%ra. she was given benadryl 50 mg iv x 1, solumedrol 125 mg iv x 1, famotidine 20 mg iv x 1, tylenol 1 g x 1, and ivf (2l). she was seen by dermatology who was concerned for - syndrome. skin biopsy was performed in the ed. id was also curbsided and recommended stopping abx (given that pt is to finish on tuesday) and admission to the icu for close monitoring. past medical history: 1. pituitary microadenoma had symptoms for years, s/p resection in at , course c/b panhypopituitarism, siadh, and hypothyroidism, transferred to rehab in , readmitted in with alpha strep bacteremia and candidemia from picc line, transferred to icu to hypotension and tachycardia, required pressors, admission c/b acute renal failure and dvt of right arm, left leg, and pe rml and rll, transitioned to lovenox, and later switched to arixtra because of suspected heparin-induced thrombocytopenia, also c/b vision loss admitted in and underwent laparascopically assisted right-sided vp shunt placement for hydrocephalus, represented to 2 days later with n/v and ha, found to have a bleed along the vp shunt, transferred to and underwent shunt revision/removal with placement of an evd drain on , drain was removed on , noted to have a leak from the burr hole from the evd drain placement, stiches were placed overnight on , developed fevers and neck stiffness on , lp was performed, started on vancomycin, ceftriaxone, and acyclovir, coverage changed to ceftazidime and vancomycin, then switched to meropenem and vancomycin, discharged on a course of ertapenem and vancomycin due to finish on 2. hypertension, 3. chronic back/hip pain 4. nephrolithiasis 5. uterine cyst s/p hysterectomy 6. esbl e.coli - treated with /ertapenem 7. dvt rue/rle and pe s/p ivc filter on social history: spanish-only speaking. married with 3 children, lives with husband and son. family history: mother with htn and oa, cousin with breast ca, no h/o coagulation disorders or anemia pertinent results: admission labs: cbc: wbc-3.7* rbc-3.73* hgb-11.2* hct-34.0* mcv-91 mch-30.1 mchc-33.0# rdw-12.5 plt ct-269 neuts-69.2 lymphs-21.6 monos-2.4 eos-6.4* baso-0.3 . pt-12.3 ptt-28.9 inr(pt)-1.0 . glucose-95 urean-10 creat-0.9 na-139 k-3.3 cl-106 hco3-23 angap-13 lactate-0.8 . ************micro*********** bcx pnd ***********radiology none yet pathology: skin, left upper outer arm; punch biopsy (a): interface dermatitis with prominent single cell dyskeratosis, focal confluent epidermal necrosis and a superficial perivascular lymphocytic infiltrate containing sparse eosinophils (see comment). comment: the histologic appearances are consistent with erythema multiforme. however, as there are areas of more confluent epidermal necrosis correlation with the clinical findings is necessary to exclude a more severe interface drug reaction in evolution. case findings discussed with dr. at ~ 1700 . slides reviewed with concurrence by dr. . . brief hospital course: erythema multiforme reaction to ertapenem) patient presented with diffuse dusky confluent erythematous rash and papules on face and involvement of upper chest, back and bilateral arms with erythematous papules and circular plaques. upper palate had bright red erythema and desquamative white mucosa. due to these findings, initially there was concern for syndrome and the patient was admitted to the icu for monitoring and treated with systemic steroids. after derm bx and further evaluation, the dermatology service concluded that the patient did not have a true syndrome but instead had an atypical erythema multiforme dermatologic reaction believed secondary to the patient's ertapenem use. the patient was treated with topical derm treatments and transferred to the hospitalist service where she was stable and discharged on daerm topical treatments with derm f/u. panhypopituitarism) outpatient hydrocortisone dose. hypothyroid) levothyroxine. dvt and pe hx) patient discharged on outpatient lovenox. seizure disorder) keppra. htn, benign) enalapril dose increased for better bp control. medications on admission: calcium 500 mg po tid enalapril 5 mg po bid hydrocortisone 20 mg po qam, 25 mg po qpm levothyroxine 100 mcg po daily levetiracetam 1000 mg po bid pantoprazole 40 mg po daily colace lovenox 60 mg sq vancomycin ertapenem lasix 40 mg po daily k 20 meq po daily discharge medications: 1. levetiracetam 500 mg tablet sig: two (2) tablet po bid (2 times a day). 2. levothyroxine 100 mcg tablet sig: one (1) tablet po daily (daily). 3. hydrocortisone 20 mg tablet sig: one (1) tablet po qam. 4. hydrocortisone 5 mg tablet sig: five (5) tablet po qpm. 5. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po once a day. 6. enalapril maleate 10 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 7. enoxaparin 60 mg/0.6 ml syringe sig: one (1) subcutaneous q12h (every 12 hours). 8. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po tid (3 times a day). 9. clobetasol 0.05 % ointment sig: one (1) appl topical (2 times a day). disp:*1 tube* refills:*6* 10. desonide 0.05 % cream sig: one (1) appl topical (2 times a day) as needed. disp:*1 tube* refills:*5* 11. heparin lock flush (porcine) 100 unit/ml syringe sig: one (1) ml intravenous daily (daily) as needed. discharge disposition: home discharge diagnosis: atypical erythema multiforme reaction to ertapenem discharge condition: vital signs stable discharge instructions: return to emergency room if having worsening skin rash, fevers, difficulty breathing, rectal or oral pain/bleeding. followup instructions: provider: scan phone: date/time: 3:00 provider: , md phone: date/time: 3:45 provider: , md phone: date/time: 3:30 procedure: venous catheterization, not elsewhere classified spinal tap incision of lung intravascular imaging of intrathoracic vessels removal of ventricular shunt closed biopsy of skin and subcutaneous tissue diagnoses: other chronic pain anemia, unspecified obstructive hydrocephalus unspecified essential hypertension unspecified acquired hypothyroidism intracerebral hemorrhage other nervous system complications pain in joint, pelvic region and thigh epilepsy, unspecified, without mention of intractable epilepsy personal history of venous thrombosis and embolism other disorders of neurohypophysis backache, unspecified other specified antibiotics causing adverse effects in therapeutic use mechanical complication of nervous system device, implant, and graft personal history of tuberculosis meningitis, unspecified panhypopituitarism panhypopituitarism 

Answer: The patient is high likely exposed to